Aytu BioPharma, Inc.(AYTU)
Pharmaceuticals
Specialty Pharma
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership change | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2025-06-10 | Disbrow Jarrett Chief Business Officer | Purchase | +16,666 | +130.24%29,462 | $1.50 | $24,999 | View SEC filing | |
| 2025-06-10 | Disbrow Joshua R. Chief Executive Officer | Purchase | +66,666 | +76.99%153,257 | $1.50 | $99,999 | View SEC filing | |
| 2025-06-09 | Nantahala Capital Management, LLC 10% Owner | Purchase | +4,000,000 | +490.67%4,815,217 | $1.50 | $5,999,600 | View SEC filing | |
| 2025-03-03 | Disbrow Joshua R. Chief Executive Officer | Purchase | +15,000 | +20.95%86,591 | $1.30 | $19,500 | View SEC filing | |
| 2023-06-20 | PYSZCZYMUKA GREG Chief Commerical Officer | Purchase | +12,000 | +120.79%21,935 | $1.87 | $22,428 | View SEC filing | |
| 2023-06-15 | Disbrow Joshua R. Chief Executive Officer | Purchase | +14,000 | +24.31%71,591 | $1.86 | $26,079 | View SEC filing | |
| 2022-12-21 | Disbrow Joshua R. Chief Executive Officer | Purchase | +112,371 | +10.04%1,231,877 | $0.22 | $25,047 | View SEC filing | |
| 2022-12-21 | PYSZCZYMUKA GREG Chief Commercial Officer | Purchase | +100,000 | +121.87%182,056 | $0.24 | $24,480 | View SEC filing | |
| 2022-11-28 | Disbrow Joshua R. Chief Executive Officer | Purchase | +222,000 | +24.74%1,119,506 | $0.24 | $52,614 | View SEC filing | |
| 2022-11-28 | Oki Mark K Chief Financial Officer | Purchase | +90,000 | +90.00%190,000 | $0.23 | $20,700 | View SEC filing | |
| 2020-12-15 | ARMISTICE CAPITAL, LLC Director | Purchase | +1,333,334 | +100.00%2,666,668 | $6.00 | $8,000,004 | View SEC filing | |
| 2020-04-29 | ARMISTICE CAPITAL, LLC Director | Sale | -5,108,921 | -100.00%0 | $1.82 | $9,298,236 | View SEC filing | |
| 2020-04-27 | Cerecor Inc. 10% Owner | Sale | -92,777 | -0.95%9,713,068 | $1.55 | $144,092 | View SEC filing | |
| 2020-03-12 | ARMISTICE CAPITAL, LLC Director | Sale | -22,026,801 | -100.00%2 | $1.42 | $31,200,123 | View SEC filing | |
| 2019-12-23 | ARMISTICE CAPITAL, LLC Director, 10% Owner | Purchase | +78,788 | +0.66%15,900,000 | $0.86 | $67,750 | View SEC filing | |
| 2019-12-19 | Disbrow Joshua R. Chief Executive Officer | Purchase | +55,000 | +11.70%525,048 | $0.89 | $48,824 | View SEC filing | |
| 2019-10-16 | ARMISTICE CAPITAL, LLC Director, 10% Owner | Purchase | +10,000,000 | +0.20%5,015,000,000 | N/A | N/A | View SEC filing | |
| 2018-12-26 | Green David A Chief Financial Officer | Sale | -3,330 | -1.24%266,250 | $0.81 | $2,711 | View SEC filing | |
| 2018-11-27 | Disbrow Joshua R. Chief Executive Officer | Purchase | +5,000 | +100.00%5,000 | $0.10 | $500 | View SEC filing | |
| 2018-03-07 | Disbrow Joshua R. Chief Executive Officer | Purchase | +452,210 | +170.75%717,054 | $0.23 | $101,747 | View SEC filing | |
| 2018-03-07 | Green David A Chief Financial Officer | Purchase | +133,200 | +177.60%208,200 | $0.23 | $29,970 | View SEC filing | |
| 2018-03-07 | Disbrow Jarrett Chief Operating Officer | Purchase | +452,210 | +211.92%665,595 | $0.23 | $101,747 | View SEC filing | |
| 2016-12-19 | Disbrow Joshua R. Chief Executive Officer | Purchase | +28,924 | +100.00%28,924 | $0.07 | $2,025 | View SEC filing | |
| 2016-11-04 | Cantrell Gary Director | Purchase | +66,666 | +102.56%131,666 | $0.75 | $50,000 | View SEC filing | |
| 2016-11-04 | Gould Gregory A Chief Financial Officer | Purchase | +133,332 | +64.44%340,231 | $0.75 | $99,999 | View SEC filing |
1-25 of 35